Later, Imai et al. (2013) further demonstrated that the mRNA expression of a cancer-type variant of SLCO1B3 in cancer cell lines is regulated by DNA methylation-dependent gene silencing involving methyl-DNA binding protein 2 (MBD2) [233]. The gene discussed is SLCO1B3; the disease is cancer.